$5m · Seed · Wellness & Beauty · London, UK
Axo Longevity, a London preventive-health membership combining more than 100 biomarker tests with ongoing tracking and personalised guidance, has raised an oversubscribed $5m seed round. MS&AD Ventures, Izou Partners, LifeX Ventures, Everywhere Ventures, UNQ, 51 Ventures, Cistern Capital and NIAN Sports & Entertainment participated alongside angel investors. The company says the funding will expand its laboratory network and services into more countries, while supporting its AI health copilot and wearable integrations.
Repeat testing makes the lab network part of the product
Preventive testing is often sold as a one-off snapshot, leaving customers to interpret results and decide what to do next. Axo packages lab access, explanation and a personalised plan into an annual membership, with testing repeated every six months. That cadence gives members a way to track change rather than collect isolated reports, and it gives the company a recurring relationship instead of a single transaction.
The difficult part is operational consistency across markets. Axo says it is live in six countries and works through a broad partner-lab network; every additional geography adds scheduling, data and service complexity. Expanding that network can make the membership more convenient, but retention will depend on whether repeat measurements and guidance feel useful enough for members to keep returning after the first results.
